J Thaddeus Beck MD FACP
Breast Cancer, Gynecologic Cancer, Head & Neck Cancer, Neuro-Oncology
Medical Director Research
Join to View Full Profile
3232 N Northhills BlvdFayetteville, AR 72703
Phone+1 479-587-1700
Fax+1 479-587-1366
Dr. Beck is on Doximity
As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
Duke University HospitalFellowship, Hematology and Medical Oncology, 1988 - 1991
University of Arkansas for Medical Sciences (UAMS) College of MedicineResidency, Internal Medicine, 1985 - 1988- University of Arkansas For Medical Sciences College of MedicineClass of 1985
Certifications & Licensure
AR State Medical License 1985 - 2026
American Board of Internal Medicine Internal Medicine- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification ARIA oncology information system (for Medical Oncology), Varian Medical Systems, 2013-2017
- CMS Meaningful Use Stage 2 Certification ARIA Oncology Information System (for Radiation Oncology), Varian Medical Systems, 2013-2017
- CMS Meaningful Use Stage 2 Certification ARIA Oncology Information System (for Medical Oncology), Varian Medical Systems, 2013-2017
Clinical Trials
- A Study of Paclitaxel Plus Bevacizumab in Patients With Chemosensitive Relapsed Small Cell Lung Cancer Start of enrollment: 2006 Apr 01
- Safety of RAD001 in Combination With Cisplatin and Etoposide in Lung Cancer Patients Start of enrollment: 2007 Apr 01
- Pharmacokinetic, Safety, and Efficacy Effects of Oral LBH589 on Dextromethorphan in Patients With Advanced or Metastatic Non-Small Cell Lung Cancer or Malignant Pleural Mesothelioma Start of enrollment: 2007 Nov 01
Publications & Presentations
PubMed
- Remote Therapeutic Monitoring and Infection-Related Health Care Resource Utilization in Patients With Hematologic Malignancies.Benjamin A Derman, James H Essell, Mustafa S Ascha, Michael A Kolodziej, Lavi Kwiatkowsky
JCO Oncology Practice. 2026-04-10 - Two Phase II Trials of Adavosertib, a Wee1 Inhibitor with Docetaxel or Carboplatin plus Pemetrexed in Non-small-cell Lung Cancer.Melissa L Johnson, Shaker R Dakhil, J Thaddeus Beck, Ahad Sadiq, Smitha Menon
Targeted Oncology. 2025-11-01 - 7 citationsPhase 1/2, open-label study of oral bacterial supplementation (EDP1503) plus pembrolizumab in participants with advanced or metastatic microsatellite-stable colorectal...Judy S Wang, Edward R Arrowsmith, J Thaddeus Beck, Jennifer Friedmann, Rahima Jamal
Investigational New Drugs. 2025-08-01
Press Mentions
Merck Cancer Shot Gets FDA Approval: What to KnowSeptember 22nd, 2025- Merck’s New Cancer Drug Option, Keytruda Qlex, Wins FDA ApprovalSeptember 22nd, 2025
- Merck Injectable Version of Blockbuster Cancer Therapy Keytruda Gets USFDA ApprovalSeptember 19th, 2025
Professional Memberships
- Member
- Fellow
- Member
- Member
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
